SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...
SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
The ongoing BIM revolution is transforming how buildings are constructed. And that’s true at every level, from the initial architectural drawings right down to the design and fabrication of metal ...
Catrin Jones explores the power of digital transformation in construction and the potential BIM has to enhance project outcomes. The construction industry recognises that Building Information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback